Russ Hullet
Co-CEO
Russ has over 35 years of experience in real estate development, having developed and invested in commercial retail/office, residential, apartment buildings, vacation rentals and vacant land. Many of these projects involved extensive renovations for which he was the general contractor or project supervisor.
He also has more than 25 years of experience conducting in-depth due diligence and investing in venture capital, private equity and startups, including in the biotech industry.
After thorough due diligence in Summit Biolab’s disruptive new direct-to-PCR technologies, Russ became the lead investor for the capital that Summit raised to launch its operations and laboratory at the Fitzsimons/CU Anschutz Medical Campus, where the company generated over $14,000,000 in revenue in its first 16 months of operations, earning gross margins of more than 70%. Summit’s remarkable success led Russ to the formation of Transformative Biotech, LLC, and the eventual acquisition of Summit Biolab’s direct-to-PCR intellectual property.
Whether it’s a real estate project or life science business investment, Russ works with a strategic eye for the most promising projects regardless of location or sector. He then proceeds with meticulous due diligence, learning every facet of the opportunity before proceeding with an investment. For projects in which he has an ongoing management role, Russ insists on a high levels of quality, integrity and performance, so that tenants, customers or colleagues will be drawn to participate. He has board (including Treasurer) level experience with private and nonprofit organizations.
Russ is currently working diligently on his ping pong skills, playing with his father-in-law and friends. He’s taken up a new sport of riding an electric hydrofoil, and plays finger-style guitar. Until the pandemic began, he and his wife hosted Living Room Live house concerts (and will again!) with nationally touring singer songwriters.
